Skip to content
LIVE · CORPUS
Dossier

Versant Vantage I GP, L.P.

Low
PersonUS
The finding

Controls or directs 10 companies in the resolved graph.

/01

Key facts

Risk signal
Controls
10 companies
Risk
Low
Jurisdiction
US

Versant Vantage I GP, L.P. controls or directs 10 companies (US).

/02

Control & directorships

Controlled by

None in current sources.

Directorships & controlled companies
/03

Directorship network

463 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

LAVA Therapeutics NV
Monte Rosa Therapeutics, Inc.
Contineum Therapeutics, Inc.
RAYZEBIO, INC.
OYSTER POINT PHARMA, INC.
Repare Therapeutics Inc.
PANDION THERAPEUTICS HOLDCO LLC
Aprea Therapeutics, Inc.
Passage BIO, Inc.
/ Community notesFREE

Analyst context the registries don’t carry — corrections, links, open questions on Versant Vantage I GP, L.P.. Notes are community-contributed leads, not verified facts.

Loading notes…